Gonen, Tal http://orcid.org/0000-0003-1820-1890
Tiosano, Shmuel http://orcid.org/0000-0002-1748-4297
Comaneshter, Doron
Amital, Howard http://orcid.org/0000-0002-5406-7716
Cohen, Arnon D. http://orcid.org/0000-0002-8377-9982
Shovman, Ora http://orcid.org/0000-0003-2416-8601
Article History
Received: 4 August 2019
Accepted: 5 October 2019
First Online: 19 October 2019
Compliance with ethical standards
:
: Relationships relevant to this manuscript within the last 3 years: Prof. Arnon Cohen received research grants from Janssen, Novartis, AbbVie, Janssen, and Sanofi. Prof. Arnon Cohen served as a consultant, advisor, or speaker to AbbVie, Amgen, Boehringer Ingelheim, Dexcel Pharma, Janssen, Kamedis, Lilly, Neopharm, Novartis, Perrigo, Pfizer, Rafa, Samsung Bioepis, Sanofi, Sirbal, and Taro. All other authors declare no conflict of interest.
: The study fulfilled the ethical guidelines of the most recent Declaration of Helsinki and received approval by the local ethical committee of the Clalit Health Services on 27/08/18. The protocol number for this study was 0212-17-COM.